DuPont: Building Higher Growth, Higher Value Through Science Douglas Muzyka, Ph.D. Senior Vice President; Chief Science & Technology Officer
|
|
- Ashlie Webster
- 5 years ago
- Views:
Transcription
1 DuPont: Building Higher Growth, Higher Value Through Science Douglas Muzyka, Ph.D. Senior Vice President; Chief Science & Technology Officer
2 Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company and allows investors to better evaluate the financial results of the company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations of non-gaap measures to GAAP are available on the Investor Center of under Key Financials & Filings. Forward Looking Statements During the course of this presentation we may make forward-looking statements or provide forward-looking information. All statements that address expectations or projections about the future are forward-looking statements. Some of these statements include words such as plans, expects, will, anticipates, "believes," intends, and estimates. Although they reflect our current expectations, these statements are not guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of which include: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; global economic and capital markets conditions; litigation and environmental matters; changes in laws and regulations or political conditions; business or supply disruptions; ability to protect and enforce the company s intellectual property rights; successful integration of acquired business and separation of underperforming or non-strategic assets; and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff. The company does not undertake to update any forward-looking statements as a result of future developments or new information. Developing Markets Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin America. A detailed list of all developing countries is available on the Earnings News Release link on the Investor Center website at 2 2
3 Our Purpose DuPont is a Science Company We work collaboratively to find sustainable, innovative, marketdriven solutions to solve some of the world s biggest challenges, making lives better, safer, and healthier for people everywhere. National Geographic image 3
4 Science is the Growth Engine for the Company Ag & Nutrition Bio-Based Industrials Advanced Materials Seeds Traits Crop Protection Specialty Food Ingredients Enzymes Biomaterials Biofuels Biochemicals Electronic Materials Protective Materials Alternative Energy Advanced Polymers Advanced Processes $ 5.8B* new product revenue $ 0.4B* new product revenue $ 3.9B* new product revenue *2013 revenue from products introduced in the last four years 4
5 Three Strategic Priorities Drive the Value of DuPont AG & NUTRITION BIO-BASED INDUSTRIALS ADVANCED MATERIALS Extend leadership across high-value, science-driven segments of the Ag and food value chain Develop world-leading industrial biotech capabilities to create new businesses Grow leading position in differentiated highvalue materials Higher Growth, Higher Value Company Through Three World-Leading Positions 5
6 Together with Three Key Operational Priorities INNOVATION GLOBAL REACH EXECUTION Rigorous pipeline management Disciplined project execution Increasing return on R&D Driving penetration in fast-growing, developing markets Delivering ongoing productivity Optimizing resource allocation Returning cash to shareholders 6
7 Delivering Value through Innovation 7
8 Disciplined Project Management Ensures Alignment Between Science and Integrated Business Innovation Processes Stage 0 Governance & Project Execution Technology Marketing Insights Brand Ideas & Opportunity Choices Launch Management Innovation Portfolio Management 8
9 Increasing our Return on R&D Key Aspects of Measurement Process Segmentation of R&D spend into 4 categories Strict financial rigor behind R&D programs Calculation of projected returns on top R&D programs Metrics package & dashboards to assess progress versus commitments R&D Spend Distribution Discovery and Major Growth Sustain and Incremental Growth Disciplined and Rigorous Process to Measure and Improve Return on R&D 9
10 Agriculture-Discovery & Major Growth : 12% Sales CAGR, Operating Margins +600bps* Rynaxypyr Insecticide Optimum AQUAmax Hybrids Exceeded $1 Billion Revenue in Million Acres Expected in 2014 *Non GAAP Number, See Appendix 10
11 Electronics & Communications-Discovery & Major Growth Industry Leading Market Positions, Innovation Fueling Earnings Growth Solamet DuPont OLED Technology Solamet Frontside Silver Pastes Advancing Solar Cell Efficiency Two License Agreements 11
12 Industrial Biosciences-Discovery & Major Growth 1 st Half 2014 Operating Earnings Increased 37%, Operating Margins Increased 440bps* Cold Water Enzymes Cellulosic Ethanol Plant Innovation of the Year** Start up expected late 2014 Nevada, Iowa *Non GAAP Number, See Appendix **2014 Sustainable Bio Award for Bio-Based Product Innovation of the Year 12
13 Nutrition & Health-Discovery & Major Growth 1 st Half 2014 Operating Earnings Increased 45%*, Operating Margins Increased 320bps* HOWARU Protect probiotics Improved Health Products for children, adults and sports enthusiasts Probiotics Regulatory Achievements & New Capacity *Non GAAP Number, See Appendix 13
14 Performance Chemicals- Discovery & Major Growth Science Meeting Market Needs for more Sustainable Solutions DuPont Opteon YF Refrigerant Collaborative approach to development A near drop-in solution to enable regulatory compliance Expect 2014 sales of $100 million 14
15 Performance Materials-Sustained and Incremental Growth 2014 Operating Margins of 19%*, Above Long Term Goal of 16-18% Zytel RS Renewable Polymers Surlyn Ionomer Five Patents Granted, Two In Progress New Golf Ball Line *Non GAAP Number, See Appendix 15
16 Safety & Protection -Sustained and Incremental Growth 1 st Half 2014 Operating Earnings increased 24%*, Operating Margins increased 330bps* New Launches DuPont Kevlar Tyvek ThermaWrap 50 Years of Innovation *Non GAAP Number, See Appendix 16
17 Putting Science to Work: Where we are Going 17
18 Translating Science into Solutions WORLD CLASS INTEGRATED SCIENCE COUPLED WITH COMPELLING MARKET INSIGHTS TO SOLVE WORLD SCALE CHALLENGES FOOD ENERGY Integration of emerging biological sciences PROTECTION Engineering Materials Science Chemistry Biological Sciences Engineering Chemistry Materials Science Biological Sciences DuPont is on the Forefront of Another Wave of Innovation 18
19 Long Term Growth Targets 7% 12% Sales CAGR Operating EPS CAGR* Ushering in the next era of innovation STRATEGIC PRIORITIES Extended Ag & Nutrition Leadership Build Bio-based Businesses Strengthen Advanced Materials OPERATIONAL PRIORITIES Innovation Global Reach Execution *Non GAAP Number 19 19
20 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES NON-GAAP RECONCILIATIONS (UNAUDITED) JUNE 30, 2014 Note : Operating earnings are defined as earnings from continuing operations (GAAP) excluding significant items and non-operating pension and other post-employment benefit (OPEB) costs. Management believes that an analysis of operating earnings, a "non-gaap" measure, is meaningful to investors because it provides insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Non-GAAP Reconciliations
21 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SEGMENT SALES (UNAUDITED) (dollars in millions) SEGMENT SALES Year Year Year Year Year Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q Q11 3Q11 2Q11 1Q Agriculture 8,009 3,615 4,394 11,739 1,806 1,633 3,631 4,669 10,426 1,535 1,423 3,388 4,080 9,166 1,297 1,368 2,997 3,504 6,549 Electronics & Communications 1, , , , ,194 Industrial Biosciences , , Nutrition & Health 1, , , , ,403 Performance Chemicals (1) 3,287 1,696 1,591 6,932 1,671 1,781 1,837 1,643 7,450 1,644 1,794 2,043 1,969 8,055 1,923 2,209 2,065 1,858 6,245 Performance Materials (1) 3,116 1,582 1,534 6,239 1,521 1,602 1,615 1,501 6,185 1,478 1,552 1,624 1,531 6,554 1,555 1,678 1,675 1,646 6,215 Safety & Protection 1,976 1, , , , , ,001 1, ,733 Other Total Segment Sales 19,992 9,783 10,209 36,046 7,814 7,813 9,925 10,494 35,194 7,397 7,480 10,022 10,295 34,087 7,444 8,236 9,263 9,144 26,499 Elimination of Transfers (158) (77) (81) (312) (67) (78) (81) (86) (382) (72) (90) (105) (115) (406) (101) (98) (104) (103) (330) CONSOLIDATED NET SALES 19,834 9,706 10,128 35,734 7,747 7,735 9,844 10,408 34,812 7,325 7,390 9,917 10,180 33,681 7,343 8,138 9,159 9,041 26,169 (1) Prior periods reflect the reclassifications of Viton fluoroelastomers from Performance Materials to Performance Chemicals. Note: The data above provides a historical display of selected data included in our Quarterly Earnings Release financials. Non-GAAP Reconciliations
22 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES INCOME FROM CONTINUING OPERATIONS (UNAUDITED) (GAAP) (dollars in millions) SEGMENT PRETAX OPERATING INCOME (LOSS) (GAAP) Year Year Year Year Year Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q Q11 3Q11 2Q11 1Q Agriculture 2, ,442 2,132 (108) (102) 861 1,481 1,669 (103) (198) 682 1,288 1,566 (222) (184) 843 1,129 1,006 Electronics & Communications (38) (99) Industrial Biosciences (26) (6) - - Nutrition & Health (20) Performance Chemicals (1) , , Performance Materials (1) , , , Safety & Protection Other (176) (84) (92) (340) (91) (107) (55) (87) (412) (80) (75) (208) (49) (55) (11) (32) 22 (34) 839 TOTAL SEGMENT PRETAX OPERATING INCOME (GAAP) 4,203 1,955 2,248 5, ,777 2,241 5, ,961 2,423 5, ,024 2,183 3,373 SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME (UNAUDITED) (dollars in millions) SEGMENT PRETAX IMPACT OF Year Year Year Year Year SIGNIFICANT ITEMS Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q Q11 3Q11 2Q11 1Q Agriculture (47) (47) - (351) (196) (40) (80) (35) (469) (26) (128) (265) (50) (225) (100) (125) - - (5) Electronics & Communications (68) (68) - (131) (131) (37) (2) (157) (37) Industrial Biosciences (2) (2) (3) - (3) - - (79) (1) (61) (17) - - Nutrition & Health (8) (8) (49) (36) (13) - - (126) (4) (89) (33) - (17) Performance Chemicals (19) (19) - (74) (2) (72) - - (36) (33) (3) (56) Performance Materials (16) (16) (104) (3) (101) (310) Safety & Protection (31) (31) (58) (3) (55) (97) Other (2) (2) (126) 11 - (137) - (28) (10) (18) - - (31) TOTAL SIGNIFICANT ITEMS BY SEGMENT - PRETAX (556) (329) (112) (80) (35) (882) (92) (460) (280) (50) (411) (68) (293) (50) - (553) OPERATING EARNINGS (UNAUDITED) (dollars in millions) SEGMENT OPERATING EARNINGS Year Year Year Year Year Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q Q11 3Q11 2Q11 1Q Agriculture 2, ,442 2, (62) 941 1,516 2,138 (77) (70) 947 1,338 1,791 (122) (59) 843 1,129 1,011 Electronics & Communications Industrial Biosciences Nutrition & Health Performance Chemicals (1) , , , Performance Materials (1) , , Safety & Protection Other (174) (82) (92) (345) (96) (107) (55) (87) (286) (91) (75) (71) (49) (27) (1) (14) 22 (34) 870 TOTAL SEGMENT OPERATING EARNINGS 4,018 1,770 2,248 5, ,857 2,276 6, ,241 2,473 6, ,215 2,074 2,183 3,926 (1) Prior periods reflect the reclassifications of Viton fluoroelastomers from Performance Materials to Performance Chemicals. Note: The data above provides a historical display of selected data included in our Quarterly Earnings Release financials. Non-GAAP Reconciliations
23 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) SEGMENT PTOI MARGIN % (PTOI / Segment Sales) (1) Year Year Year Year Year Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q Q11 3Q11 2Q11 1Q Agriculture 27.9% 21.8% 32.8% 18.2% -6.0% -6.2% 23.7% 31.7% 16.0% -6.7% -13.9% 20.1% 31.6% 17.1% -17.1% -13.5% 28.1% 32.2% 15.4% Electronics & Communications 8.0% 3.4% 12.9% 8.0% -5.9% 15.2% 14.5% 8.0% 8.2% 6.6% -16.3% 27.8% 8.7% 13.8% 9.7% 14.3% 14.1% 16.2% 9.6% Industrial Biosciences 18.3% 18.0% 18.6% 13.9% 12.6% 14.8% 14.1% 14.2% 13.5% 13.7% 12.7% 14.0% 13.5% 0.3% 11.8% -8.9% -4.9% n/m n/m Nutrition & Health 10.6% 10.5% 10.8% 8.8% 10.0% 9.3% 7.1% 8.8% 7.9% 2.6% 7.3% 11.9% 9.8% 3.1% 6.7% -2.4% 2.9% 8.6% 1.3% Performance Chemicals (2) 13.3% 13.7% 12.9% 13.6% 13.6% 10.6% 14.6% 15.6% 24.5% 12.8% 23.2% 30.0% 29.8% 26.8% 25.8% 29.5% 27.7% 23.9% 9.9% Performance Materials (2) 30.7% 42.0% 19.1% 20.3% 18.3% 22.9% 20.6% 19.1% 17.3% 17.8% 14.4% 20.0% 17.1% 15.7% 13.4% 15.0% 16.1% 18.3% 1.3% Safety & Protection 17.9% 17.3% 18.5% 17.9% 21.8% 17.4% 16.9% 15.2% 14.7% 13.5% 9.9% 18.4% 16.9% 16.8% 13.9% 16.2% 18.0% 19.1% 16.1% TOTAL SEGMENT PTOI MARGIN % 21.0% 20.0% 22.0% 14.9% 7.8% 9.5% 17.9% 21.4% 15.3% 7.1% 6.2% 19.6% 23.5% 17.3% 10.1% 11.2% 21.9% 23.9% 12.7% SEGMENT OPERATING EARNINGS MARGIN % (Operating Earnings / Segment Sales) (1) Agriculture 28.4% 23.1% 32.8% 21.2% 4.9% -3.8% 25.9% 32.5% 20.5% -5.0% -4.9% 28.0% 32.8% 19.5% -9.4% -4.3% 28.1% 32.2% 15.4% Electronics & Communications 13.7% 14.4% 12.9% 13.1% 14.5% 15.2% 14.5% 8.0% 9.6% 6.9% 9.6% 12.5% 8.7% 13.8% 9.7% 14.3% 14.1% 16.2% 11.3% Industrial Biosciences 18.6% 18.6% 18.6% 13.8% 12.3% 14.8% 14.1% 14.2% 13.7% 13.7% 13.7% 14.0% 13.5% 11.5% 12.1% 11.9% 8.9% n/m n/m Nutrition & Health 11.1% 11.3% 10.8% 8.6% 9.3% 9.3% 7.1% 8.8% 9.3% 6.8% 8.8% 11.9% 9.8% 8.2% 7.2% 8.2% 9.7% 8.6% 2.5% Performance Chemicals (2) 13.9% 14.8% 12.9% 14.6% 13.8% 14.7% 14.6% 15.6% 25.0% 14.8% 23.4% 30.0% 29.8% 26.8% 25.8% 29.5% 27.7% 23.9% 10.8% Performance Materials (2) 19.1% 19.2% 19.1% 20.5% 19.3% 22.9% 20.6% 19.1% 19.0% 18.0% 20.9% 20.0% 17.1% 15.0% 10.4% 15.0% 16.1% 18.3% 6.3% Safety & Protection 19.4% 20.3% 18.5% 17.8% 21.4% 17.4% 16.9% 15.2% 16.2% 13.8% 15.7% 18.4% 16.9% 16.8% 13.9% 16.2% 18.0% 19.1% 18.7% TOTAL SEGMENT OPERATING EARNINGS MARGIN % 20.1% 18.1% 22.0% 16.4% 12.0% 10.9% 18.7% 21.7% 17.8% 8.3% 12.3% 22.4% 24.0% 18.5% 11.0% 14.8% 22.4% 23.9% 14.8% (1) Segment PTOI / Operating Earnings margin %'s for Other are not presented separately above as they are not meaningful; however, the results are included in the Total margin %'s above. (2) Prior periods reflect the reclassifications of Viton fluoroelastomers from Performance Materials to Performance Chemicals. Non-GAAP Reconciliations
24 Copyright 2014 DuPont. All rights reserved. The DuPont Oval Logo, DuPont TM, The miracles of science TM, and all products denoted with or M are trademarks or registered trademarks of E. I. du Pont de Nemours and Company.
Credit Suisse Chemical & Ag Science Conference
Credit Suisse Chemical & Ag Science Conference Ellen Kullman Executive Vice President E. I. du Pont de Nemours and Company September 17, 2008 New York 2 Regulation G The attached charts include company
More informationKuraray to Acquire DuPont Glass Laminating Solutions/Vinyls
Contacts: Kuraray DuPont Tomoyuki Shimamoto Carole Davies +81-3-6701-1071 +1-248-583-8112 kuraraykoho@kuraray.co.jp carole.a.davies@dupont.com Kuraray to Acquire DuPont Glass Laminating Solutions/Vinyls
More informationQ2 Fiscal Year 2017 Conference Call. February 15, 2017
Q2 Fiscal Year 2017 Conference Call February 15, 2017 FORWARD-LOOKING STATEMENTS This presentation contains projections and other forward-looking statements regarding future events or the future financial
More informationKforce Inc. J.P. Morgan Ultimate Services Investor Conference November 14, 2017
Kforce Inc. J.P. Morgan Ultimate Services Investor Conference November 14, 2017 Forward Looking Statements All of the information presented that is not historical in nature should be considered to be forward-looking
More informationForward-Looking Statements
Forward-Looking Statements This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks,
More information2017 Fourth Quarter Earnings. March 2018
2017 Fourth Quarter Earnings March 2018 Disclaimer The information is provided for informational purposes only, and is not an offer to buy or sell or a solicitation of an offer to buy or sell any security
More informationLevel 3 and tw telecom: Strengthening Level 3 s Position as a Premier Global Communications Company. Level 3 To Acquire tw telecom
Level 3 To Acquire tw telecom June 16, 2014 tw telecom s U.S.-based, enterprise-focused business is highly complementary to Level 3 s local-to-global business and positions Level 3 as a premier provider
More informationWimm Bill Dann Acquisition
Wimm Bill Dann Acquisition December 2, 2010 Safe Harbor Statement Statements in this communication that are forward looking statements, including any statements regarding the business outlook of PepsiCo
More informationInvestor Presentation
Investor Presentation Q4 FY 2017 Content India Improved rankings Exports Rupee appreciation hurting Financial Highlights Consistent Performance Infrastructure Plan, Prepare, Perform 2 of 33 India 3 of
More informationOVERVIEW. Helping people live healthier lives and helping make the health system work better for everyone
OVERVIEW Helping people live healthier lives and helping make the health system work better for everyone About UnitedHealth Group UnitedHealth Group helps drive positive change in health care in the United
More informationCONTENTS. 1. Keep Challenging. 2. The CXO Challenge. 3. The CXO Problem Statement. 4. Timelines. 5. Prizes. 6. General Guidelines. 7.
CONTENTS 1. Keep Challenging 2. The CXO Challenge 3. The CXO Problem Statement 4. Timelines 5. Prizes 6. General Guidelines 7. Contest Rules 8. Cognizant Contact 1. KEEP CHALLENGING Over the past 20 years,
More informationAMN Healthcare Investor Presentation
AMN Healthcare Investor Presentation September 2017 The Innovator in Healthcare Workforce Solutions and Staffing Services Forward-Looking Statements This investor presentation contains forwardlooking statements
More information1 st Quarter FY2016 IR Presentation
1 st Quarter FY2016 IR Presentation Zhaopin Limited Nov 2015 Safe Harbor Statement and Disclaimer This presentation contains forward-looking statements made under the safe harbor provisions of Section
More informationInterim Report. First quarter 2017, BioPorto Group. May 4, 2017 Announcement no. 09. BioPorto A/S CVR DK
Interim Report First quarter 2017, BioPorto Group May 4, 2017 Announcement no. 09 BioPorto A/S CVR DK-17500317 Highlights US clinical trials for The NGAL Test initiated and sales of the test has grown
More informationNeedham Growth Conference. January 12, 2012
Needham Growth Conference Forward Looking Statements Certain statements made in this presentation that are not based on historical information are forward-looking statements which are made pursuant to
More informationAMN Healthcare Investor Presentation
AMN Healthcare Investor Presentation May 2017 The Innovator in Healthcare Workforce Solutions and Staffing Services Forward-Looking Statements This investor presentation contains forwardlooking statements
More informationJ.P. MORGAN GLOBAL HIGH YIELD & LEVERAGED FINANCE CONFERENCE FEBRUARY 29, 2016
J.P. MORGAN GLOBAL HIGH YIELD & LEVERAGED FINANCE CONFERENCE FEBRUARY 29, 2016 Forward-Looking Statements This presentation may contain forward-looking statements based on current management expectations.
More informationAMN Healthcare Investor Presentation
AMN Healthcare Investor Presentation Q1 2015 The Innovator in Healthcare Workforce Solutions and Staffing Services Forward-Looking Statements This investor presentation contains forward-looking statements
More informationInvestor Presentation Q1 FY 2017
Investor Presentation Q1 FY 2017 www.ajantapharma.com 1 of 27 Content Financial Highlights Industry Update India Financial Highlights Emerging Markets USA Infrastructure 2 of 27 India 3 of 27 India Branded
More informationProgram Guidelines Accelerating Food Innovation in Alberta: Application of Research or Technology for New Product Development
Program Guidelines 2017 18 Accelerating Food Innovation in Alberta: Application of Research or Technology for New Product Development 2 Program Guidelines 1.1 Purpose The 2017 18 Accelerating Food Innovation
More informationKentucky New Energy Ventures. Scope & Goals. 1. Grow alternative fuel and renewable energy companies in Kentucky to drive statewide economic growth;
Kentucky New Energy Ventures Scope & Goals 1. Grow alternative fuel and renewable energy companies in Kentucky to drive statewide economic growth; 2. Stimulate private investment in Kentucky-based alternative
More informationGeneral premises for Building World-class Excellence in Response to Regional Needs:
D R AF T The University of Akron: Driving Economic Competitiveness for North East Ohio GLOBALLY DISTINCTIVE POLYMER SCIENCES AND ENGINEERING APPLIED IN REGIONAL INDUSTRY CLUSTERS March 14, 2008 Strategic
More informationAMN Healthcare Investor Presentation
AMN Healthcare Investor Presentation August 2016 The Innovator in Healthcare Workforce Solutions and Staffing Services Forward-Looking Statements This investor presentation contains forwardlooking statements
More informationBANK OF AMERICA MERRILL LYNCH 2016 LEVERAGED FINANCE CONFERENCE NOVEMBER 29, 2016
BANK OF AMERICA MERRILL LYNCH 016 LEVERAGED FINANCE CONFERENCE NOVEMBER 9, 016 Forward-Looking Statements This presentation may contain forward-looking statements based on current management expectations.
More informationAMN Healthcare Investor Presentation
AMN Healthcare Investor Presentation November 2016 The Innovator in Healthcare Workforce Solutions and Staffing Services Forward-Looking Statements This investor presentation contains forwardlooking statements
More informationInnovation Partnership Zones
Innovation Partnership Zones Building a World Class Innovation Ecosystem Presentation for : Innovation Awards The Council of State Governments Edmonton, Alberta July 19, 2012 Egils Milbergs Executive Director
More information3 rd quarter results 2009
3 rd quarter results 2009 revenue trend gradually turning; increased gross margin pressure largely offset by continued strong cost management RobertJan van de Kraats, CFO Randstad Holding nv October 29,
More informationCanadian Agricultural Automation Cluster: Call for Proposals
Canadian Agricultural Automation Cluster: Call for Proposals Deadline: 5pm EST Tuesday November 14, 2017 The Initiative: Vineland Research and Innovation Centre (Vineland) is currently developing a large-scale
More informationBIOMINAS BRASIL. Your ideal partner to succeed in life sciences in Latin America Dedicated to create and develop business in life sciences since 1990
BIOMINAS BRASIL Your ideal partner to succeed in life sciences in Latin America Dedicated to create and develop business in life sciences since 1990 BIOMINAS BRASIL ACTIVITIES ARE DISTRIBUTED IN FOUR MAIN
More informationFY 2017 results. Financial Details Contacts, Calendar & Disclaimer
1 2 Financial Details Contacts, Calendar & Disclaimer Financial Highlights m FY 2016 FY 2017 % YoY Sales 38,173 37,965-1 EBITDA 1 4,939 4,955 +0 EBIT 1 3,112 3,074-1 Adjusted net income 1 904 1,427 +58
More informationNearshoring is a valuable part of a company's logistics strategy
An Agility White Paper Nearshoring is a valuable part of a company's logistics strategy - 1 - Nearshoring is a valuable part of a company's logistics strategy Many companies have already had experiences
More informationAlliance Mid-Atlantic March 06, 2012
1 1 Alliance Mid-Atlantic March 06, 2012 2 2 Purpose Review Small Business/Supplier Diversity Program at DuPont Process Rollout the elements of the Program Review the qualification requirements Review
More informationABMS Organizational QI Forum Links QI, Research and Policy Highlights of Keynote Speakers Presentations
ABMS Organizational QI Forum Links QI, Research and Policy Highlights of Keynote Speakers Presentations When quality improvement (QI) is done well, it can improve patient outcomes and inform public policy.
More informationAMN Healthcare Investor Presentation
AMN Healthcare Investor Presentation May 2018 The Innovator in Healthcare Workforce Solutions and Staffing Services Forward-Looking Statements This investor presentation contains forwardlooking statements
More informationOur strategic vision
1 Our story. Our future. Our strategic vision 2013 2017 The University of Texas Health Science Center at San Antonio Making Lives Better through Excellence Because of the efforts of faculty, students and
More informationCAMDEN CLARK MEDICAL CENTER:
INSIGHT DRIVEN HEALTH CAMDEN CLARK MEDICAL CENTER: CARE MANAGEMENT TRANSFORMATION GENERATES SAVINGS AND ENHANCES CARE OVERVIEW Accenture helped Camden Clark Medical Center, (CCMC), a West Virginia-based
More informationJ.P. MORGAN 35 TH ANNUAL HEALTHCARE CONFERENCE JANUARY 9-12, 2017
J.P. MORGAN 35 TH ANNUAL HEALTHCARE CONFERENCE JANUARY 9-1, 017 Forward-Looking Statements This presentation may contain forward-looking statements based on current management expectations. Numerous factors,
More informationUSER EXPERIENCES ON EUROPEAN COMMISION PUBLIC FUNDING SINISEN KASVUN EU-RAHOITUSINFO MATTI HEIKKILÄ
USER EXPERIENCES ON EUROPEAN COMMISION PUBLIC FUNDING SINISEN KASVUN EU-RAHOITUSINFO MATTI HEIKKILÄ 4.12.2017 METGEN AT A GLANCE Finnish SME, founded 2008, Headcount 20 Awarded technologies and industrial
More information29th John Ruffatto Business Startup Challenge - April 13, 2018 Competition Overview & Guidelines
Judging Criteria 1 Submission Process & Deadlines: 1 Competition Day Format 2 Written Submission Guidance 2 Financial Projection Guidance 4 Presentation Guidance 5 Judging Criteria Your team may want to
More informationINTEGRATED INFRASTRUCTURE
13286_Half_year_20.qxp 11/8/ 21:04 Page 3 Half-year update 20 INTEGRATED INFRASTRUCTURE Pre-tax profit up 14% to 108m Order book of 12.5bn Significant profit growth in building sector, driven by particularly
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K CURRENT REPORT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event
More informationCLP CLIMATE ACTION BOND
CLP CLIMATE ACTION BOND DNV GL 2ND PARTY OPINION Scope and Objectives CLP Holdings Limited (CLP) (henceforth referred to as CLP ) is one of the largest investor-owned power businesses with presence in
More informationR&D Tax Credits. Energy and natural resources sector
R&D Tax Credits Energy and natural resources sector 1 Cash refunds for R&D expenditure Energy and natural resources Overview As global economic activity shifts towards innovation and knowledge, Ireland
More informationForward Looking Statements
Forward Looking Statements All of the information presented that is not historical in nature should be considered to be forward-looking statements that are subject to certain risks, uncertainties or assumptions
More informationDuPont Refrigerants. It s a Chilling Reality. Counterfeit Refrigerants are on the rise... Chillventa Refrigerants Forum No.
DuPont Refrigerants It s a Chilling Reality Counterfeit Refrigerants are on the rise... Chillventa Refrigerants Forum No.4 October 9, 2012 Beth Sassano Global Marketing Manager DuPont Fluorochemicals 1
More informationHEALTHCARE STAFFING EDUCATION & TRAINING SEARCH
HEALTHCARE STAFFING EDUCATION & TRAINING SEARCH February 2006 This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events
More informationQ2 Revenue at 1,631 crore up 22% YoY; EBITDA at INR 338 Crore, up 65% YoY
Q2 Revenue at 1,631 crore up 22% YoY; EBITDA at INR 338 Crore, up 65% YoY Press Release Mumbai, India, November 5 th, 2012 Tech Mahindra, India s sixth largest software exporter today announced its audited
More informationPushing Case Management into the Future: Six Requirements to Drive Clinical and Financial Returns
Pushing Case Management into the Future: Six Requirements to Drive Clinical and Financial Returns Authors: Loren Mann, Mark Werner, MD and Cynthia Bailey Hospital-based case management (CM) should be a
More informationIdentifying Evidence-Based Solutions for Vulnerable Older Adults Grant Competition
Identifying Evidence-Based Solutions for Vulnerable Older Adults Grant Competition Pre-Application Deadline: October 18, 2016, 11:59pm ET Application Deadline: November 10, 2016, 11:59pm ET AARP Foundation
More informationASPEN GROUP, INC. October 2017 Nasdaq: ASPU.
ASPEN GROUP, INC. October 2017 Nasdaq: ASPU www.aspen.edu SAFE HARBOR STATEMENT Certain statements in this presentation and responses to various questions include forward-looking statements including statements
More informationPilot Study: Optimum Refresh Cycle and Method for Desktop Outsourcing
Intel Business Center Case Study Business Intelligence Pilot Study: Optimum Refresh Cycle and Method for Desktop Outsourcing SOLUTION SUMMARY The Challenge IT organizations working with reduced budgets
More informationMaryland Technology Enterprise Institute
Maryland Technology Enterprise Institute web: www.mtech.umd.edu tel: (301) 405-3906 fax: (301) 403-4105 Educate, Create, Connect Maryland Technology Enterprise Institute The mission of Mtech is to: Educate
More informationDigital Disruption: Embracing an Integrated Digital Ecosystem
08 Digital Disruption: Embracing an Integrated Digital Ecosystem Digital Disruption: Embracing an Integrated Digital Ecosystem 08 In Short The of Launching a Tech Startup Has Dropped Dramatically 33 2010
More informationTerms of Reference. Digital Fundraising Consultant. Private Sector Partnerships Service (PSP), UNHCR London, UK
Terms of Reference Digital Fundraising Consultant Private Sector Partnerships Service (PSP), UNHCR London, UK UNHCR, the UN Refugee Agency, is offering a consultancy contract within the Private Sector
More informationWhat next for Life Sciences? Vir Lakshman
What next for Life Sciences? Vir Lakshman CEO&CFO Gipfel BioDeutschland Reutlingen, Germany 3 rd December 2015 Big pharma is making deals, not drugs FINANCIAL TIMES November, 25th 2015 Life Sciences M&A
More informationPhase II Transition to Scale
Phase II Transition to Scale Last Updated: July 11, 2013 FULL PROPOSAL INSTRUCTIONS Grand Challenges Canada is dedicated to supporting bold ideas with big impact in global health. We are funded by the
More information2017 Earnings release
2017 Earnings release 1 DISCLAIMER This presentation contains historical information of the company which should not be regarded as an indication of the future performance or results. This presentation
More informationNewYork-Presbyterian An Academic, Integrated Delivery System. April 2017
An Academic, Integrated Delivery System April 2017 Laura Forese, MD EVP and COO Hospital has 6 Campuses Across Manhattan and Westchester 2 NYPH: A Major Academic Medical Center (2016) Key Facts Inpatient
More informationFinancial Results for the 3 rd Quarter of Fiscal Year Ending December 31, 2016
OUTSOURCING Inc. (Securities Code: 2427/TSE 1st Section) Financial Results for the 3 rd Quarter of Fiscal Year Ending December 31, 2016 Copyright (C) OUTSOURCING Inc. All Rights Reserved. Contents P. 2
More informationStrategic Directions to Advance Innovation-Led Growth and High- Quality Job Creation Across the Commonwealth
January 2018 WORKING DRAFT OF EXECUTIVE SUMMARY Assessment of Virginia s Research Assets: Strategic Directions to Advance Innovation-Led Growth and High- Quality Job Creation Across the Commonwealth Prepared
More informationGlanbia Graduate Programme 2013 Niamh Hayden, HR Business Support Manager
Glanbia Graduate Programme 2013 Niamh Hayden, HR Business Support Manager 9 th October 2012 Leading global nutritional solutions and cheese group Who we are International nutritional solutions and cheese
More informationPrinciples of Health Science
Core provides knowledge and skills students need for careers in health care. Students explore the services, structure, and professions of the health care system and get guidance on choosing a specific
More informationHealth Science Foundations
Core provides knowledge and skills students need for careers in health care. Students explore the services, structure, and professions of the health care system and get guidance on choosing a specific
More informationNicole Bartley Charles Adeyanju
Nesta Ogunmuyiwa Nicole Bartley Charles Adeyanju Hyderabad Cluster Introduction Hyderabad constitutes the fifth largest metropolitan city of India. Also the capital of southern state Andhra Pradesh, the
More informationHORIZON The Structure and Goals of the Horizon 2020 Programme. Horizont 2020 Auftaktveranstaltung München, 04. Dezember 2013
HORIZON 2020 The Structure and Goals of the Horizon 2020 Programme Horizont 2020 Auftaktveranstaltung München, 04. Dezember 2013 Wolfgang Boch Head of Unit EC, DG CONNECT The Multiannual Financial Framework
More informationCharitable Giving Grant Application 2014
Charitable Giving Grant Application 2014 Our Vision A world with increased opportunity for all, through better access to education and technology. Our Mission Our mission is to leverage Blackboard s unique
More informationLife Sciences Tax Incentive Program
Life Sciences Tax Incentive Program Solicitation No. 2017 TAX-01 Program Manager: Cheryl Sadeli, Vice President of Finance Questions: Taxprogram@masslifesciences.com Solicitation Issued: December 4, 2017
More informationEZYHEALTH SET TO TRANSFORM INTO A BILLION DOLLAR PALM OIL AGRI- BUSINESS
Citigate Dewe Rogerson, i.mage Pte Ltd (RCB No. : 198802344W) 1 Raffles Place #26-02 OUB centre Singapore 048616 Tel: (65) 6534 5122 Fax: (65) 6534 4171 NEWS RELEASE EZYHEALTH SET TO TRANSFORM INTO A BILLION
More informationInvestor Presentation: Q Results Update
Investor Presentation: Q4 2014 Results Update Important Disclaimer This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter.
More informationKindred, Centerre and RehabCare
Kindred, Centerre and RehabCare Creating the Nation s Premier Inpatient Rehabilitation Provider November 2014 Forward Looking Statements Certain statements contained herein contain forwardlooking statements
More informationEVERGREEN IV: STRATEGIC NEEDS
United States Coast Guard Headquarters Office of Strategic Analysis 9/1/ UNITED STATES COAST GUARD Emerging Policy Staff Evergreen Foresight Program The Program The Coast Guard Evergreen Program provides
More informationConsumers can t keep up with rising costs of medications
UX AWARDS 2017 Consumers can t keep up with rising costs of medications Every year, Americans fill millions of prescriptions, spending billions of dollars as the cost of healthcare continues to rise. Many
More informationOhio Third Frontier Program
Ohio Third Frontier Program Overview Created in 2002, the Ohio Third Frontier is an unprecedented commitment to create new technology-based products, companies, industries and jobs. In May, the Ohio Third
More informationThe Software Industry Financial Report
The Software Industry Financial Report Executive Summary Software Equity Group, L.L.C. 12220 El Camino Real Suite 320 San Diego, CA 92130 info@softwareequity.com (858) 509-2800 2015 Annual Software Industry
More informationGODREJ INDUSTRIES LIMITED
GODREJ INDUSTRIES LIMITED Performance Update Q3 & 9M FY 2016-17 FEBRUARY 14, 2017 1 I Godrej Industries Limited I Q3 & 9M FY 2016-17 Performance Update February- 14, 2017 DISCLAIMER Some of the statements
More informationNavigating the road to Opportunities and challenges for telecom operators in the Middle East
Navigating the road to 2020 Opportunities and challenges for telecom operators in the Middle East 2 Navigating the road to 2020: opportunities and challenges for telecom operators in the Middle East Executive
More informationSTEP Agri-Value. Food Ingredients Europe November 28-30, 2017 Frankfurt, Germany TRIP REPORT
STEP Agri-Value Food Ingredients Europe November 28-30, 2017 Frankfurt, Germany TRIP REPORT Notice to Recipient: The attached information is provided by STEP on the express condition that the recipient
More informationBut We re Not DuPont How All In-House Departments Can Add Value Through Business Discipline
But We re Not DuPont How All In-House Departments Can Add Value Through Business Discipline Notes on the remarks of Thomas L. Sager, Sr. VP & General Counsel, DuPont Company WMACCA Luncheon on May 28,
More informationNFMRI. National Foundation for Medical Research and Innovation. Impact giving Advancing medical innovations
NFMRI National Foundation for Medical Research and Innovation Impact giving Advancing medical innovations Philanthropy has the freedom to think different, do different, & make a difference. Medical innovation
More informationPinellas County Florida. Business Incentive Program
Pinellas County Florida Business Incentive Program October 2003 Business Incentive Program Pinellas County, Florida Prepared for the Pinellas County Planning Council October - 2003 Prepared by William
More information< < < Finance and Accounting. Health and Life Sciences > > > < < < Government Solutions
< < < Finance and Accounting Technology >>> Health and Life Sciences > > > < < < Government Solutions 2006 Annual Report Kforce Inc. (NASDAQ: KFRC) is a full-service, specialty staffing Firm providing
More informationCorporate Presentation JULY 2015
Corporate Presentation JULY 2015 Agenda Global Tile Industry Indian Tile Industry Kajaria Ceramics overview Financials Shareholding Pattern 2 The production of top 10 countries (Million Sq Mtr) CY09 CY10
More informationGuidelines for Funding
Guidelines for Funding June 1, 2017 Genome Canada Guidelines for Funding Contents 1. Introduction... 3 2. General Guidelines... 3 2.1 Eligibility Requirements... 3 2.1.1. Eligible Institutions... 3 2.1.2.
More informationInvestor Presentation 3 rd Qtr. - FY 2018
Investor Presentation 3 rd Qtr. - FY 2018 25 th January, 2018 1 of 34 Content Content INDIA 1 India 2 Global 3 Infrastructure 4 Financial Highlights 5 Recognition 2 of 34 INDIA 1 India 3 of 34 India Branded
More informationOutsourcing biopharmaceuticals manufacturing Best practices when working with external supply partners
Outsourcing biopharmaceuticals manufacturing Best practices when working with external supply partners Dr. Ulrich Rümenapp, Bayer AG Biologics & Biosimilars Congress 1-2 February 2016 Berlin, Germany Outline
More informationI 2 Program Frequently Asked Questions
I 2 Program Frequently Asked Questions What is the Genome BC Industry Innovation (I 2 ) Program? The I 2 Program offers repayable growth capital to businesses (with less than 500 employees), commercializing
More informationAnnual results: Net income from ordinary operations increased by 21%
. Annual results 2002 For more information, please contact: Sandra van Campen Phone: +31 20 569 5623 Diemen, February 18, 2003 Annual results: Net income from ordinary operations increased by 21% Highlights
More informationTransforming The Process Industries
The requested format for all proposals submitted to RAPID is outlined here. There is a 12-page limit to each proposal, excluding the title page and Supplemental Information section. Proposals should retain
More informationDebi Durham Director Iowa Economic Development Authority
Debi Durham Director Iowa Economic Development Authority Historic Preservation Tax Credits» The State Historic Preservation and Cultural and Entertainment District Tax Credit program (HPCED) provides
More informationAlfred E. Mann Foundation for Biomedical Engineering
Alfred E. Mann Foundation for Biomedical Engineering Venture Philanthropy and Directed Philanthropy as a New Mode of Capitalization to Move University Scientific and Technological Research to the Marketplace
More informationPlans to introduce Robotics in seven key locations to provide cutting edge clinical care and augment the Centers of Excellence delivery.
Delivers superior results aided by sustained revenue growth Continue to set new standards in medical technology through introduction of Robotics Q2FY12 Consolidated Revenues up 20.4% at Rs. 7,848 million
More informationRose Consulting Service
West Central Clean Energy Resource Team Grant Opportunities Discussion 21June, 2007 Sunburg, MN Rose Consulting Service grant assistance includes: Deciphering grant requirements to guide you through the
More informationMassachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry
Massachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry Massachusetts State Profile 5 Key Programs & Initiatives The opportunities generated by the biopharmaceutical sector as a leader
More informationRenewable Energy Tax Incentives Program
Renewable Energy Tax Incentives Program Calendar Year 2016 Annual Report Prepared by the: Table of Contents Incentive Overview... 3 Reporting Requirements... 4 Calendar Year 2016 Program Activity... 4
More information2017 Small Business Grant Pilot Program APPLICATION
2017 Small Business Grant Pilot Program APPLICATION Made possible by the Garland Chamber of Commerce, Garland Economic Development Partnership The Garland Chamber of Commerce, as part of its role in the
More information2009 Annual Report TECHNOLOGY FINANCE AND ACCOUNTING HEALTH AND LIFE SCIENCES GOVERNMENT SOLUTIONS
2009 Annual Report TECHNOLOGY FINANCE AND ACCOUNTING HEALTH AND LIFE SCIENCES GOVERNMENT SOLUTIONS Kforce Inc. (NASDAQ: KFRC) is a full-service, specialty staffing Firm providing flexible and permanent
More informationInnovative Commercialization Efforts Underway at the National Renewable Energy Laboratory
Innovative Commercialization Efforts Underway at the National Renewable Energy Laboratory ABSTRACT Kate Cheesbrough and Meghan Bader, National Renewable Energy Laboratory New clean energy and energy efficiency
More informationReducing the High Cost of Patient Non-Adherence:
Reducing the High Cost of Patient Non-Adherence: Navigating the Optimal Journey to Improved Outcomes By Amy Parke, Vice President Integrated Marketing Communications, Ashfield Healthcare Communications
More informationSkilled Nursing Facilities in Pennsylvania: Analysis of Total Profit Margins for Freestanding Facilities
Skilled Nursing Facilities in Pennsylvania: Analysis of Total Profit Margins for Freestanding Facilities Avalere Health March 2016 Avalere Health T 202.207.1300 avalere.com An Inovalon Company F 202.467.4455
More informationInvestor Presentation. February 2017
Investor Presentation February 2017 Disclaimer This presentation contains historical information of the company which should not be regarded as an indication of future performance or results. This presentation
More information